AzTrials
AzTrials

Knee OsteoarthritisNCT02003976

A Randomized Trial Comparing High Tibial Osteotomy Plus Non-Surgical Treatment and Non-Surgical Treatment Alone

A study testing Medial Opening Wedge High Tibial Osteotomy (HTO) and Non-Surgical Treatment Program in people with Knee Osteoarthritis, run by Western University, Canada at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to compare patients with knee osteoarthritis (OA) receiving optimized non-surgical treatment plus surgical realignment of the tibia, or optimized non-surgical treatment only. Read more about this study

Who is it for?
Ages 25 to 55 years
Conditions the study is for
Knee Osteoarthritis
What is being tested?
Medial Opening Wedge High Tibial Osteotomy (HTO) and Non-Surgical Treatment Program
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
71 participants
Where
1 siteCanada
Study dates
5 Sep 2014to 26 Apr 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 55 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Is the subject either:
  • 25-55 years old?
  • Older than 55 but still active (ex. physical labour, regular recreational activities)?
  • Does this subject present with varus alignment? (Based on hip to ankle x-rays).
  • Does this subject have clinical Knee OA? (MAA <-2° on full limb standing AP) according to the Altman classification primarily involving the medial compartment of the knee?
  • Patient is a good candidate for high tibial osteotomy and will be receiving a PEEK plate, or if receiving an alternate plate, agrees to have the plate removed prior to 1 year postoperative.

Who cannot join

  • Has this subject had a previous HTO or joint replacement in either limb?
  • Is this subject likely to undergo bilateral HTO within the 2 year follow up period?
  • Does this subject have an unstable knee or ligament?
  • Does this subject have inflammatory or infectious arthritis of the knee?
  • Radiographic disease too advanced for HTO (ie. diffuse lateral compartment, patellofemoral joint OA and/or severe enough disease to suggest that joint replacement is the better surgical option) and/or Kellgren and Lawrence grade 4.
  • The subject's disease is not advanced enough (symptomatically or radiographically) to warrant HTO.
Show all 12Show fewer
  • Does this subject have a major medical illness with life expectancy <2 years or with an unacceptably high operative risk?
  • Does this subject have a major neurological deficit that would affect gait?
  • Is this subject possibly pregnant or planning pregnancy?
  • Is this subject unable to read English?
  • Does this subject have a psychiatric illness that limits informed consent?
  • Is the subject unlikely to comply with study protocol?

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Fowler Kennedy Sport Medicine Clinic, Western University

    London, Ontario, N6A 3K7

Other trials in Canada

About this study

The purpose of this study is to compare patients with knee osteoarthritis (OA) receiving optimized non-surgical treatment plus surgical realignment of the tibia, or optimized non-surgical treatment only. We hypothesize that outcomes assessed at 12 and 24 months follow-up will suggest favourable changes in patients undergoing surgical realignment when compared to patients receiving non-surgical treatment only.

Read the detailed description

This two groups, parallel design randomized controlled trial will compare patients with medial compartment knee OA and varus alignment receiving optimized non-surgical treatment plus High Tibial Osteotomy (HTO) to similar patients receiving optimized non-surgical treatment only. All participants will receive non-surgical treatment that will be individualized to the patient and include medications, physiotherapy and nutritional seminars. The non-surgical treatment will include supervised physiotherapy and nutritional seminars once per week for 12 weeks, will be accompanied and followed by a home program, and follow-up appointments for potential modification every three months for the duration of the study. Participants randomized to surgery will also undergo medial opening wedge HTO after 12 weeks of optimized non-surgical treatment. Both groups will follow the same schedule of clinic visits throughout the 24 month follow-up period. MRI-derived measures of articular cartilage morphology, biological markers of articular cartilage degradation and synthesis, gait biomechanics and patient-reported outcomes will be assessed at baseline, 12 and 24 months follow-up.

Being tested
Medial Opening Wedge High Tibial Osteotomy (HTO), Non-Surgical Treatment Program
Keywords
knee osteoarthritis, high tibial osteotomy, gait analysis, muscular strength, body composition, magnetic resonance imaging, biological markers
Medical subject headings
Osteoarthritis, Knee

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Medial Opening Wedge High Tibial Osteotomy (HTO)Procedure or surgery

    A lower limb realignment surgery to redistribute load away from the most affected portion of the knee.

  • Non-Surgical Treatment ProgramOther

    A 12-week optimized non-surgical treatment program consisting of medication, physiotherapy and nutritional seminars.

Study groups in NCT02003976
Study groupRoleWhat they receive
Non-Surgical Treatment plus HTOExperimentalThe optimized non-surgical treatment program consists of medications, physiotherapy and nutritional seminars. The 12-week program will include an assessment by a primary care physician, physiotherapist and orthopaedic surgeon, one supervised physiotherapy session per week, one body recomposition session per week, and a home program. After the 12-week program is completed, patients randomized to this group will undergo a medial opening wedge high tibial osteotomy (HTO). They will continue with their home program and will be followed up for 2 years after baseline.
Receives: Procedure: Medial Opening Wedge High Tibial Osteotomy (HTO); Other: Non-Surgical Treatment Program
Non-Surgical TreatmentActive comparatorThe optimized non-surgical treatment program consists of medications, physiotherapy and nutritional seminars. The 12-week program will include an assessment by a primary care physician, physiotherapist and orthopaedic surgeon, one supervised physiotherapy session per week, one body recomposition session per week, and a home program. After the 12-week program is completed, patients randomized to this group will continue with their home program and will be followed up for 2 years after baseline.
Receives: Other: Non-Surgical Treatment Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. MRI articular cartilage morphology

    3 Tesla MRI measure of medial tibiofemoral articular cartilage thickness

    Measured: Change from baseline to 24 months post operative

Secondary outcomes (9)
  1. Knee Injury and Osteoarthritis Outcome Score (KOOS)

    Patient-reported outcome measure. 5 subdomains: pain, symptoms, activities of daily living, sport and recreation, quality of life

    Measured: Change from baseline to 24 months post operative

  2. Western Ontario Meniscal Evaluation Tool (WOMET)

    Patient-reported outcome measure. Assesses health-related quality of life (HRQoL) in patients with meniscal tears. 3 dimensions: physical symptoms, sports/recreation/work/lifestyle, emotions

    Measured: Change from baseline to 24 months post operative

  3. Biological Markers of Disease Progression

    Synovial fluid, serum and urine biological markers

    Measured: Baseline, 12 and 24 months post operative

  4. Numeric Rating Scale for Pain

    Patient-reported outcome measure. Assesses patient's pain. 0 (no pain) - 10 (worst possible pain)

    Measured: Baseline, 12 and 24 months post operative

  5. Gait Biomechanics

    Knee frontal, sagittal and transverse plane kinematics and kinetics tested during level walking in a motion analysis laboratory. The measure of most interest is the peak external knee adduction moment during stance phase of walking.

    Measured: Baseline, 12 and 24 months post operative

  6. Isometric Strength Testing

    Isometric quadriceps and hamstrings strength tested using an isokinetic dynamometer.

    Measured: Baseline, 12 and 24 months post operative

  7. Intermittent and Constant Osteoarthritis Pain Index (ICOAP)

    Patient-reported outcome measure. Assesses pain in individuals with hip or knee osteoarthritis taking into account both constant and intermittent pain. 3 domains: intermittent pain, constant pain, total pain

    Measured: Change from baseline to 24 months post operative

  8. Short-Form 12 (SF12)

    Patient-reported outcome measure. Self-reported outcome measure assessing the impact of health on an individual's everyday life

    Measured: Change from baseline to 24 months post operative

  9. Western Ontario and McMaster Universities Arthritis Index (WOMAC)

    Patient-reported outcome measure. 3 sub domains: pain, symptoms, function

    Measured: Change from baseline to 24 months post operative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Dec 2013 (estimated)
  2. Study start5 Sep 2014
  3. Primary completion18 Apr 2023
  4. Study completion26 Apr 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
71 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02003976
Sponsor's protocol ID
TAS-SOG-13-020
Other IDs
MOP-133489
Status last verified
Jul 2024
First submitted
2 Dec 2013
Last updated
24 Jul 2024
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Publications

  • Birmingham TB, Primeau CA, Moyer RF, Bryant DM, Ma J, Leitch KM, Wirth W, Degen R, Getgood AM, Litchfield RB, Willits KR, Eckstein F, Giffin JR. High Tibial Osteotomy for Medial Compartment Knee Osteoarthritis : A Randomized Trial With Parallel Preference Arm. Ann Intern Med. 2025 Sep;178(9):1238-1248. doi: 10.7326/ANNALS-25-00920. Epub 2025 Jul 29.

    PubMed 40720836

Questions about this trial

What is this clinical trial studying?

A study testing Medial Opening Wedge High Tibial Osteotomy (HTO) and Non-Surgical Treatment Program in people with Knee Osteoarthritis, run by Western University, Canada at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

MRI articular cartilage morphology (time frame: Change from baseline to 24 months post operative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02003976, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in